Hypersensitivity to isosorbide or known idiosyncratic reaction to organic nitrates. Increased intracranial pressure (e.g. head trauma or cerebral hemorrhage). Withhold treatment in the presence of cardiogenic shock, or if there is a risk of shock developing.